Company / Return on Equity (ROE)
Chemed Corp. Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
27.1%
FY2025
5-year range
24.6% / 43.1%
FY2021-FY2025
Trend
+0.3%
vs FY2024
Sector context
#10 of 147
Health Care
What the data says
Among 147 Health Care companies, Chemed Corp. is in the top 7% for return on equity (roe). Return on Equity (ROE) has fluctuated over the past 10 years, ranging from 18.2% in FY2017 to 43.1% in FY2021.
Based on SEC 10-K filings.
27.1% in FY2025 with a 5-year CAGR of -8.4%. Top quartile in the Health Care sector.
Improved from 24.6% to 27.1% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -4.2pp
- 5-Year Change
- -8.4pp
- 10-Year Change
- -
Sector benchmark
Top 7% in Health CareTop 7% of 147This company 27.1% Sector average -3.1%
▼
+967.8% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 0.3% year-over-year.
- Currently 30.2pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2021.
- Lowest return on equity (roe) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 27.1% | +0.3% |
| FY2024 | 27.0% | +9.7% |
| FY2023 | 24.6% | -21.3% |
| FY2022 | 31.3% | -27.5% |
| FY2021 | 43.1% | +21.6% |
| FY2020 | 35.4% | +17.1% |
| FY2019 | 30.3% | -12.9% |
| FY2018 | 34.8% | +91.3% |
| FY2017 | 18.2% | -12.4% |
| FY2016 | 20.8% | -3.4% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026